Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anders Ekblom Insider Profile
4 Followers
Anders Ekblom, Director at Mereo BioPharma, holds 96.70K shares in Mereo BioPharma (Ticker: GB:MPH), holds 13.10K shares in AstraZeneca (Ticker: GB:AZN). Most recently, Anders Ekblom Bought ― shares of Mereo BioPharma on Nov 22, 2019 for an estimated value of 25.50K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-16.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anders Ekblom holds in companies
Most Profitable Insider Trade
The most profitable trade made by Anders Ekblom
Anders Ekblom's Trading History
Mereo BioPharma
Nov 22, 2019
Director
Informative Buy
25.50K
£31.91K
AstraZeneca
May 06, 2011
Executive Vice-President & Development
Informative Sell
107.29K
£1.02M
List of latest transactions for each holding click on a transaction to see Anders Ekblom's performance on stock
You May Also Like
Anders Ekblom insider profile FAQ
What is the percentage of profitable transactions made by Anders Ekblom?
The percentage of profitable transactions made by Anders Ekblom is 50%.
What is the average return per transaction made by Anders Ekblom?
The average return per transaction made by Anders Ekblom is -16.70%.
What stocks does Anders Ekblom hold?
Anders Ekblom holds: GB:MPH, GB:AZN stocks.
What was Anders Ekblom’s latest transaction?
Anders Ekblom latest transaction was an Informative Buy of 25.50K.
What was Anders Ekblom's most profitable transaction?
Anders Ekblom’s most profitable transaction was an Informative Sell of GB:AZN stock on September 9, 2010. The return on the trade was 11.10%.
What is Anders Ekblom's role in Mereo BioPharma?
Anders Ekblom's role in Mereo BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.